EverSource Wealth Advisors LLC lowered its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 91.1% in the ...

BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Tuesday. BMRN has ...

The drug is the only treatment available for the debilitating and progressive condition, and works by replacing the N-acetylgalactosamine-6-sulfatase enzyme lacking in people with the disease.

After hours: March 14 at 7:41:01 PM EDT Loading Chart for BMRN ...

Department of Neurology, Dokkyo University School of Medicine, Tochigi, Japan ...

Pre-market: 4:20:27 am GMT-4 Loading Chart for BMRN ...

Department of Chemistry, University of California, Davis, Davis, California 95616, United States Genome Center, University of California, Davis, California 95616 ...